Effect on blood pressure of oral appliance therapy for sleep apnea syndrome

Department of Oral and Maxillofacial Surgery, Graduate School of Medicine, Kyoto University, Japan.
The International journal of prosthodontics (Impact Factor: 1.46). 01/2006; 19(1):61-6.
Source: PubMed


The aim of this study was to evaluate the effect of individually prescribed oral appliances for the treatment of obstructive sleep apnea syndrome (OSAS) on blood pressure, as well as factors influencing the efficacy.
One hundred sixty-one patients (121 men and 40 women, mean age: 54.3 +/- 13.7 years) diagnosed with mild to moderate OSAS (mean apnea-hypopnea index: 17.9 +/- 14.1) were studied before and after insertion of a mandibular advancement device, with a mean interval of 60 days. Systolic, diastolic, and mean blood pressure was taken using an automatic blood pressure monitor (132.0 +/- 16.1 mmHg, 82.1 +/- 10.6 mmHg, 107.1 +/- 12.9 mmHg, respectively, at baseline).
The patients were subdivided into 3 groups: responder, partial responder, and nonresponder, according to the difference of mean arterial pressure fall after the treatment. The systolic, diastolic, and mean blood pressure decreased significantly (P < .001) (127.5 +/- 15.0 mmHg, 79.2 +/- 10.0 mmHg, 103.4 +/- 12.0 mmHg, respectively) after the insertion of the device. The oral appliance therapy produced falls in blood pressure (4.5 mmHg, 3.0 mmHg, 3.7 mmHg, respectively). The response was significantly (P < .001) correlated to baseline blood pressure. The responders (n = 70, mean blood pressure fall > 3.7 mmHg) and the partial responders (n=46, 0 < fall < or = 3.7 mmHg) showed significantly (P < .05; analysis of variance) higher reduction in apnea-hypopnea index (69.6%, 65.9%, respectively) than that (52.5%) of nonresponders (n=45, fall < or =0 mmHg).
These data suggest that effective oral appliance therapy for OSAS patients with hypertension can lead to a substantial reduction in daytime blood pressure.

2 Reads
  • Source

    Full-text · Article ·
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Central sleep apnea (CSA) is characterized by the periodic occurrence of apnea caused by loss of ventilatory motor output. CSA is often discussed as a minor variant of obstructive sleep apnea.However, this view obscures the critical contribution of CSA as an important manifestation of breathing instability in a variety of conditions with diverse causes. Central apnea can also be a physiologic phenomenon in healthy people during sleep onset. Conversely, patients who have obstructive apnea may also develop episodes of apparent central apnea, and apneas that begin as central may become obstructive as respiratory effort is restored ("mixed apneas"). Thus, there is a significant overlap between obstructive and central apnea. This article addresses the pathophysiology, clinical features, and management of normocapnic and hypercapnic CSA.
    Full-text · Article · Jul 2005 · Primary Care Clinics in Office Practice
  • [Show abstract] [Hide abstract]
    ABSTRACT: Oral appliances are an established treatment option for snoring and mild obstructive sleep apneaa-hypopnea (OSAH). Oral appliance therapy is a noninvasive, reversible approach to treatment. Oral appliances appear to work by increasing upper airway space, stabilizing the anterior position of the mandible, advancing the tongue or soft palate, or both, and possibly by changing upper airway muscle activity. Randomized, controlled trials of oral appliance therapy have shown a good efficacy in patients with mild to moderate OSAH and in some patients with more severe OSAH. In most of the studies, patients preferred the oral appliance over continuous positive airway pressure (CPAP), although CPAP was more effective in reducing the apneaa-hypopnea index (AHI).
    No preview · Chapter · Dec 2005
Show more